Abstract:Abstract Cre-mediated recombineering is the main tool of choice for cell type-specific analysis of gene function in pre-clinical models. In the type 1 diabetes research field, multiple lines of NOD mice have been generated that express Cre in pancreatic β-cells using insulin promoter fragments, but tissue promiscuity remains a concern. The constitutive Ins1 tm1.1(cre)Thor ( Ins1 Cre ) mouse on a C57/bl6-J background has been shown to have high β-cell specificity and with no off-target effects reported. Therefore, we explored if Ins1 Cre mice on an NOD background could be used as a novel tool to investigate β-cell specific gene deletion in a type 1 diabetes setting. Here, we examine a new NOD mouse model in which Cre is inserted into the endogenous Ins1 locus for ideal β-cell specificity. Fully wildtype ( Ins1 WT/WT ), Ins1 heterozygous ( Ins1 Cre/WT or Ins1 Neo/WT ), and Ins1 null mice ( Ins1 Cre/Neo ) littermate mice had either none, one or two Ins1 alleles replaced with Cre or a neomycin cassette. Female Ins1 Neo/WT mice exhibited significant protection from type 1 diabetes. Ins1 Cre/WT knock-in mice were further protected. The effects of combined neo and Cre knock-in in Ins1 Neo/Cre mice were additive and resulted in near-complete type 1 diabetes prevention up to one year of age. In Ins1 Neo/Cre mice, protection from diabetes was associated with reduced in insulitis at 12 weeks of age. We were unable to find significant differences in insulin auto-antibodies or in immune populations between genotypes in the pancreatic lymph node or spleen in 50 weeks old mice, suggesting a β-cell specific mechanism. Collectively, these data confirm previous reports that the loss of Ins1 alleles protects NOD mice from diabetes and demonstrates, for the first time, that Cre itself may have additional protective effects. This has significant implication for the experimental design and interpretation of pre-clinical type 1 diabetes studies using β-cell-specific Cre in NOD mice.

Transgenic Insulin (B:9-23) T-Cell Receptor Mice Develop Autoimmune Diabetes Dependent Upon RAG Genotype, H-2g7 Homozygosity, and Insulin 2 Gene Knockout

Human insulin as both antigen and protector in type 1 diabetes

B lymphocyte "original sin" in the bone marrow enhances islet autoreactivity in type 1 diabetes-prone nonobese diabetic mice

Insulin-Reactive T Cells Convert Diabetogenic Insulin-Reactive VH125 B Cells Into Tolerogenic Cells by Reducing Germinal Center T:B Cell Interactions in NOD Mice

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

Cloned T cells from a recent onset IDDM patient reactive with insulin B-chain

Unexpected acceleration of type 1 diabetes by transgenic expression of B7-H1 in NOD mouse peri-islet glia

An altered CD8 + T cell epitope of insulin prevents type 1 diabetes in humanized NOD mice

Regulatory CD4+ T cells redirected against pathogenic CD8+ T cells protect NOD mice from development of autoimmune diabetes

A Single L/D-Substitution at Q4 of the mInsA2-10 Epitope Prevents Type 1 Diabetes in Humanized NOD Mice

CD4+ T cells reactive to a hybrid peptide from insulin-chromogranin A adopt a distinct effector fate and are pathogenic in autoimmune diabetes

Natural Killer Cells Modulate Overt Autoimmunity to Homeostasis in Nonobese Diabetic Mice after Anti-CD3 F(ab′)2 Antibody Treatment through Secreting Transforming Growth Factor-β

Beyond Knockout: A Novel Homodimerization-Targeting MyD88 Inhibitor Prevents and Cures Type 1 Diabetes in NOD Mice

A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen

Foxp3-expressing CD4+T Cells under the Control of IFN-γ Promoter Prevent Diabetes in NOD Mice

Interleukin‐17‐producing Γδ+ T Cells Protect NOD Mice from Type 1 Diabetes Through a Mechanism Involving Transforming Growth Factor‐β

Beta-cell Cre expression and reduced Ins1 gene dosage protect mice from type 1 diabetes

T Cell Receptor Genotype and Ubash3a Determine Susceptibility to Rat Autoimmune Diabetes

A Novel Immunodeficient Hyperglycemic Mouse Carrying the Ins1 Akita Mutation for Xenogeneic Islet Cell Transplantation

Insulin-degrading enzyme regulates insulin-directed cellular autoimmunity in murine type 1 diabetes

A post-translational cysteine-to-serine conversion in human and mouse insulin generates a diabetogenic neoepitope